For the Inventor, By the Inventor

Enter assignee name

Vienna, Austria

Baxter Innovations Gmbh

USPTO Granted Patents = 12

EPO Patents = 1

Forward Citations = 25

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Friedrich Dorner (8 out of 91 patents)

Manfred Reiter (6 out of 71 patents)

Wolfgang Mundt (6 out of 63 patents)

4. Hans-Peter Schwarz (4 out of 105 patents)

5. Peter Turecek (4 out of 118 patents)

6. Artur Mitterer (4 out of 53 patents)

7. Randolf Kerschbaumer (3 out of 16 patents)

8. Friedrich Scheiflinger (3 out of 76 patents)

9. Gerhard Antoine (3 out of 11 patents)

10. Miha Furlan (3 out of 13 patents)

11. Bernhard Laemmle (3 out of 7 patents)

12. Helena Elisabeth Schaller-Gerritsen (3 out of 5 patents)

13. Luigina Tagliavacca (3 out of 6 patents)

14. Klaus Zimmermann (3 out of 10 patents)

15. Leopold Grillberger (2 out of 42 patents)

12 patents: Sort by Forward Citations

1. 8722406 - Medium for the protein-free and serum-free cultivation of cells (2014-05-13),

2. 8703426 - Composition exhibiting a von Willebrand Factor (vWF) protease activity with the amino acid sequence AAGGILHLELLV (2014-04-22),

3. 8329465 - Recombinant cell clones having increased stability and methods of making and using the same (2012-12-11),

4. 8084252 - Recombinant cell clones having increased stability and methods of making and using the same (2011-12-27),

5. 8084251 - Recombinant cell clones having increased stability and methods of making and using the same (2011-12-27),

6. 8080414 - Recombinant cell clones having increased stability and methods of making and using the same (2011-12-20),

7. 8021881 - Medium for the protein-free and serum-free cultivation of cells (2011-09-20),

8. 7910094 - Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV (2011-03-22),

9. 7648958 - Factor VIII/vWF-complex and methods of purifying same (2010-01-19),

10. 7557188 - Methods of treating blood coagulation disorders using a pharmaceutical preparation comprising vWF propeptide (2009-07-07),

11. 7501117 - Composition exhibiting a von Willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV (2009-03-10),

12. 7498146 - Stable factor VIII/von willebrand factor complex (2009-03-03),

Baxter Innovations GmbH is a cutting-edge technology company specializing in the development of innovative solutions. With a focus on research and development, we strive to deliver advanced products and services that meet the evolving needs of our clients. Our expertise lies in areas such as artificial intelligence, robotics, and automation. Through constant innovation, we aim to transform industries and drive positive change in the world.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

12 Patents

#65 in Vienna

#265 in Austria

#46,738 in the World

Vienna, Austria

Baxter Innovations Gmbh

Forward Citations = 25

22 inventors:

Friedrich Dorner (8 out of 91 patents)

Manfred Reiter (6 out of 71 patents)

Wolfgang Mundt (6 out of 63 patents)

4. Hans-Peter Schwarz (4 out of 105 patents)

5. Peter Turecek (4 out of 118 patents)

Please report any incorrect information to support@idiyas.com

Loading…